Literature DB >> 25266740

Versatile carboxymethyl chitin and chitosan nanomaterials: a review.

Deepa Narayanan1, R Jayakumar, K P Chennazhi.   

Abstract

Biocompatibility, biodegradability, and low cost of chitin and chitosan have drawn immense attention in many fields including medicine, bioinspired material science, pharmaceuticals, and agriculture. Their handling and processing are difficult owing to its insolubility in neutral aqueous solution or organic solvents. One of the methods used to improve the solubility characteristics of chitin and chitosan is chemical modification. Introducing a carboxymethyl group is the most advantageous method of increasing the solubility of chitosan at neutral and alkaline pH. Carboxymethyl chitin (CMC) and carboxymethyl chitosan (CMCS) are water soluble derivatives formed by introducing CH₂COOH function into the polymer which endows it with better biological properties. The functional group makes CMC/CMCS nanoparticles (NPs) efficient vehicles for the delivery of DNA, proteins, and drugs. This review provides an overview of the characteristics of CMC/CMCS NPs as well as fulfills the task of describing and discussing its important roles primarily in cancer nanomedicine detailing the targeted drug delivery aspect. The application of these NPs in imaging, agriculture, and textiles has also been highlighted. The review also elaborates the advantages of using the CMC and CMCS NPs for drug and gene delivery.
© 2014 Wiley Periodicals, Inc.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 25266740     DOI: 10.1002/wnan.1301

Source DB:  PubMed          Journal:  Wiley Interdiscip Rev Nanomed Nanobiotechnol        ISSN: 1939-0041


  6 in total

Review 1.  Current progress in nanotechnology applications for diagnosis and treatment of kidney diseases.

Authors:  Sue Hyun Lee; Jung Bok Lee; Min Soo Bae; Daniel A Balikov; Amy Hwang; Timothy C Boire; Il Keun Kwon; Hak-Joon Sung; Jae Won Yang
Journal:  Adv Healthc Mater       Date:  2015-06-29       Impact factor: 9.933

Review 2.  Recent Advances in Chitosan and its Derivatives in Cancer Treatment.

Authors:  Jingxian Ding; Yonghong Guo
Journal:  Front Pharmacol       Date:  2022-04-28       Impact factor: 5.988

3.  The Targeted Antitumor Effects of C- PC/CMC-CD59sp Nanoparticles on HeLa Cells in Vitro and in Vivo.

Authors:  Yujuan Wang; Liangqian Jiang; Qifeng Yin; Huihui Liu; Guoxiang Liu; Guoteng Zhu; Bing Li
Journal:  J Cancer       Date:  2017-08-25       Impact factor: 4.207

4.  Oral Administration of Nanopeptide CMCS-20H Conspicuously Boosts Immunity and Precautionary Effect Against Bacterial Infection in Fish.

Authors:  Xingchen Huo; Zhensheng Wang; Xun Xiao; Chunrong Yang; Jianguo Su
Journal:  Front Immunol       Date:  2022-01-11       Impact factor: 7.561

5.  Carboxymethyl chitosan prolongs adenovirus-mediated expression of IL-10 and ameliorates hepatic fibrosis in a mouse model.

Authors:  Yannian Gou; Yaguang Weng; Qian Chen; Jinghong Wu; Hao Wang; Jiamin Zhong; Yang Bi; Daigui Cao; Piao Zhao; Xiangyu Dong; Meichun Guo; William Wagstaff; Bryce Hendren-Santiago; Connie Chen; Andrew Youssef; Rex C Haydon; Hue H Luu; Russell R Reid; Le Shen; Tong-Chuan He; Jiaming Fan
Journal:  Bioeng Transl Med       Date:  2022-03-10

Review 6.  Orally Administrable Therapeutic Nanoparticles for the Treatment of Colorectal Cancer.

Authors:  Kangkang Ying; Bingjun Bai; Xing Gao; Yuzi Xu; Hangxiang Wang; Binbin Xie
Journal:  Front Bioeng Biotechnol       Date:  2021-07-07
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.